Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
The Efficacy and Safety of Varenicline, a...
Conference

The Efficacy and Safety of Varenicline, a Selective Alpha4beta2 Nicotinic Receptor Partial Agonist, for Smoking Cessation in Patients Hospitalized With Acute Coronary Syndrome: A Randomized Controlled Trial

Authors

Eisenberg MJ; Windle SB; Roy N; Old W; Grondin F; Bata I; Iskander A; lauzon C; Srivastava N; Clarke A

Volume

132

Pagination

pp. 2269-2270

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

December 8, 2015

Name of conference

Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium

Conference place

Chicago, IL

Conference start date

November 15, 2015

Conference end date

November 19, 2015

Conference proceedings

CIRCULATION

Issue

23

ISSN

0009-7322